Panbela Announces Validation of European Patent in UK, Italy, Germany, France, and Spain for Claims of a Novel Process for the Production of SBP-101GlobeNewsWire • 10/31/23
Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online PublicationGlobeNewsWire • 10/25/23
Panbela to Host Third Quarter 2023 Earnings Conference Call on November 9, 2023GlobeNewsWire • 10/24/23
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101GlobeNewsWire • 09/26/23
Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of FlynpoviGlobeNewsWire • 09/05/23
Panbela to Present at H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 08/28/23
Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101GlobeNewsWire • 08/14/23
Panbela to Host Second Quarter 2023 Earnings Conference Call on August 10, 2023GlobeNewsWire • 07/31/23
Panbela Opens Enrollment in UK and Germany for Aspire Trial in Pancreatic Cancer, All Countries/Regions in the Aspire Trial are Now Open and Actively EnrollingGlobeNewsWire • 07/24/23
Panbela Therapeutics to Receive a Total Up to $9.5 Million for Divestiture of Assets within Eflornithine (DFMO) Pediatric Neuroblastoma Program to US WorldMedsGlobeNewsWire • 07/19/23
Panbela Announces Issuance of New Patent in Australia Patent is for Claims of a Novel Process for the Production of SBP-101GlobeNewsWire • 07/15/23
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In July - Cibus (NASDAQ:CBUS), Bellerophon Therapeutics (NASDAQ:BLPH)Benzinga • 07/05/23
Panbela Announces PACES S0820 Phase III Trial Passes Pre-Planned Futility AnalysisGlobeNewsWire • 06/28/23
Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 DiabetesGlobeNewsWire • 06/26/23
Panbela Announces Sponsored Research Agreement to Evaluate Polyamine Metabolic Inhibitor Therapy in Combination with CAR-T Cell TherapyGlobeNewsWire • 06/13/23
Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 DiabetesGlobeNewsWire • 06/01/23